13
Mar
2015
Ember Therapeutics, After Shutting Down, Pools IP With Mariel
This content is available for subscribers of the Timmerman Report. Subscribe Now Sign in to your account.
The Timmerman Report Gives You Consistent In-Depth Reporting on Biotechnology. Get Your Edge.
Already have an account?
Please sign in to your account.
My name is Luke Timmerman. I’m a biotechnology journalist, author, and entrepreneur.